Welcome to our dedicated page for Accuray Incorp SEC filings (Ticker: ARAY), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Accuray Incorporated (NASDAQ: ARAY) SEC filings page on Stock Titan provides centralized access to the company’s regulatory disclosures, including annual reports, quarterly reports and current reports on Form 8-K. As a radiation oncology company that develops and manufactures systems such as the CyberKnife and Radixact platforms, Accuray uses its SEC filings to report on financial performance, capital structure, governance decisions and material corporate events that matter to ARAY shareholders and analysts.
In its periodic reports, such as the Form 10-K and Form 10-Q, Accuray presents audited and unaudited financial statements, segment information, discussions of product and service revenue, gross profit, operating expenses, net income or loss, cash and debt balances, and non-GAAP measures like adjusted EBITDA. These filings also contain risk factor disclosures and management’s discussion and analysis, which address topics such as macroeconomic conditions, supply chain dynamics, tariffs, international operations and joint venture arrangements.
Current reports on Form 8-K provide more immediate insight into specific developments. Recent 8-K filings describe amendments to a financing agreement with TCW Asset Management Company LLC, including changes to liquidity calculations, delayed draw term loan conditions and covenant timing, as well as the issuance of warrants to purchase shares of common stock with defined exercise prices, terms and anti-dilution provisions. Other 8-Ks cover restructuring actions under a strategic, operational and organizational transformation plan, including workforce reductions and estimated restructuring charges, and governance matters such as equity incentive plan approvals, director elections, executive transitions and consulting arrangements.
Proxy materials, including the definitive proxy statement on Form DEF 14A, outline proposals submitted to stockholders, such as director elections, approval of the 2026 Equity Incentive Plan, advisory votes on executive compensation and ratification of the independent registered public accounting firm. These documents also describe corporate governance practices, board structure and executive compensation programs.
On Stock Titan, these filings are supplemented by AI-powered summaries that highlight key points from lengthy documents, helping users quickly understand the significance of each filing. Real-time updates from the SEC’s EDGAR system ensure that new 10-K, 10-Q and 8-K reports, as well as proxy statements and other relevant forms, are available as they are filed. For those tracking insider-related information, Form 4 and other ownership filings can be reviewed alongside financial and governance disclosures to build a more complete picture of Accuray’s regulatory and corporate history.
Accuray Incorporated filed a Form S-8 registration statement to register shares of its common stock for issuance under the Accuray Incorporated 2026 Equity Incentive Plan
The filing incorporates by reference Accuray’s latest Annual Report on Form 10-K for the year ended June 30, 2025, its Quarterly Report on Form 10-Q for the quarter ended September 30, 2025, recent Current Reports on Form 8-K, and the existing description of its common stock. It also describes the company’s Delaware-law based indemnification protections for directors and officers, including charter and bylaw provisions, separate indemnification agreements, and directors’ and officers’ liability insurance.
Accuray Inc. (ARAY) CEO and director Stephen R. La Neve reported an open-market purchase of 20,000 shares of common stock on 11/19/2025. The transaction was reported at a weighted average purchase price of $0.9705 per share, with individual trades executed between $0.9699 and $0.9708. Following this purchase, La Neve beneficially owns 20,000 shares directly. The filing notes that detailed trade-by-trade pricing information within the stated range is available upon request.
Accuray Incorporated reported results from its 2025 Annual Meeting of Stockholders. Stockholders elected three Class I directors — Anne B. Le Grand, Joseph E. Whitters and Chan W. Galbato — to serve until the 2028 annual meeting, each receiving more votes for than against. Stockholders also approved the Company’s 2026 Equity Incentive Plan, with 54,189,859 shares in favor and 8,102,765 against, allowing Accuray to continue granting equity-based awards to employees and directors. In an advisory vote, stockholders approved compensation for the Company’s named executive officers, and they ratified the appointment of Grant Thornton LLP as independent registered public accounting firm for the fiscal year ending June 30, 2026.
Accuray Inc. director Robert Kill reported the conversion of 56,603 restricted stock units into common stock on 11/13/2025 at an exercise price of $0 per share. Following this transaction, he beneficially owned 162,809 shares of Accuray common stock directly. The RSUs were originally scheduled to vest 100% on 11/21/2025, but the vesting and settlement into shares were accelerated to 11/13/2025 in connection with his retirement from the Board of Directors.
Accuray Inc. director reports no share ownership. A director of Accuray Inc. (ARAY) has filed a beneficial ownership report stating that no securities of the company are beneficially owned. The filing confirms that the individual serves as a director but does not currently hold Accuray common stock or derivative securities such as options or warrants.
Accuray (ARAY) filed its quarterly report showing a wider loss amid higher financing costs and softer product demand. Net revenue was $93.9 million, down from $101.5 million a year ago, as product sales fell while services grew. Gross profit declined to $26.5 million. Operating expenses were $37.9 million, and interest expense rose to $8.1 million, reflecting the new credit facilities and paid‑in‑kind interest. The company recorded a $1.9 million non‑cash loss from warrant remeasurement.
Accuray reported a net loss of $21.7 million (−$0.18 per share) versus a $4.0 million loss last year. Operating cash flow improved to $12.2 million, supported by accounts receivable collections, while inventories increased. Cash and cash equivalents were $63.3 million; total assets were $456.8 million and stockholders’ equity was $61.9 million. The company ended the quarter with $167.5 million of debt outstanding (net carrying value $140.2 million) and remained in compliance with debt covenants. Remaining performance obligations totaled $866.0 million. Management initiated a restructuring, eliminating about 3% of the workforce and recording $1.5 million in severance and $1.3 million in consulting costs.
Accuray Incorporated furnished an 8‑K announcing its fiscal 2026 first quarter results. The company provided a press release for the quarter ended September 30, 2025, and made an investor presentation available.
The materials were furnished under Item 2.02 and Item 7.01 and are not deemed filed. The press release is attached as Exhibit 99.1, and the earnings call presentation as Exhibit 99.2. The presentation will also be available on Accuray’s investor relations website.
Accuray (ARAY)1,250,000 Restricted Stock Units (RSUs) and 1,250,000 Performance Stock Units (PSUs), each unit representing the right to receive one share of common stock.
The RSUs vest in four equal tranches, with 25% on each of the first, second, third, and fourth anniversaries of the grant date. The PSUs vest upon Accuray’s common stock achieving a specified price per share during designated performance periods. Following the reported transactions, 1,250,000 RSUs and 1,250,000 PSUs are shown as beneficially owned, held directly.
Accuray Inc. (ARAY) reported an insider ownership update. Stephen R. La Neve—identified as both CEO and Director—filed a Form 3 with an event date of 10/20/2025, stating that no securities are beneficially owned.
Form 3 is an initial statement of beneficial ownership for company insiders. This filing is administrative and indicates that, as of the event date, the reporting person did not hold Accuray equity or derivative positions.
Accuray (ARAY) reported an officer transaction tied to RSU settlement on 10/31/2025. The filer acquired 37,500 shares of Common Stock at $0 via transaction code M and had 12,001 shares withheld at $1.41 under code F to cover taxes. Following these entries, the officer beneficially owned 25,499 shares directly. Derivative holdings reflected 112,500 Restricted Stock Units after the transaction, with RSUs vesting 25% annually over four years from grant.